Find a Doctor or Practice Location

Medical School: Albert Ludwig's University
Residency: University of Maryland Hospital
Fellowship: University of Maryland Hospital

American College of Gastroenterology, National American Federation for Medical Research, National American Gastroenterological Association, National Asia America Assembly of IBD, International Crohn's and Colitis Foundation of America, National Network of Healthcare Advisors, National

Hospital Privileges:

• Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
• Penn Medicine Radnor: Has privileges to perform procedures.
• Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.

Selected Publications:

Lin S, Han Y, Jenkin K, Lee SJ, Sasaki M, Klapproth JM, He P, Yun CC: Lysophosphatidic Acid Receptor 1 Is Important for Intestinal Epithelial Barrier Function and Susceptibility to Colitis Am J Pathol 188 (2): 353-66,2018.

Brant SR, Okou DT, Simpson CL, Cutler DJ, Haritunians T, Bradfield JP, Chopra P, Prince J, Begum F, Kumar A, Huang C, Venkateswaran S, Datta LW, Wei Z, Thomas K, Herrinton LJ, Klapproth JMA, Quiros AJ, Seminerio J, Liu Z, Alexander JS, Baldassano RN, Dudley-Brown S, Cross RK, Dassopoulos T, Denson LA, Dhere TA, Dryden GW, Hanson JS, Hou JK, Hussain SZ, Hyams JS, Isaacs KL, Kader H, Kappelman MD, Katz J, Kellermayer R, Kirschner BS, Kuemmerle JF, Kwon JH, Lazarev M, Li E, Mack D, Mannon P, Moulton DE: Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease Gastroenterology 152 (1): 206-17,2017.

Klapproth JMA: Inflammatory Bowel Disease Essentials of Gastroenterology 2 : 2017.

Dalal R, Klapproth JMA and Lichtenstein GR: “Trick of the Trade in treating Patients with IBD Inflammatory Bowel Disease: Diagnosis and Therapeutics 3 : 2017.

Klapproth JMA: Acute Diarrhea Essentials of Gastroenterology 2 : 2017.

Klapproth JMA and Lichtenstein GR: Infliximab in “Crohn’s Disease and Ulcerative Colitis" Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach Biologic Therapy for Crohn's disease : 2017.

Klapproth JK: Review and Assessment Gastrointestinal and Liver Disease 10 : 2016.

JMA Klapproth and GR Lichtenstein: Biologic Therapy for Crohn's disease: Infliximab, in Crohn’s Disease and Ulcerative Colitis Springer Publishing Co : 2016.

Regueiro MD, Greer JB, Binion DG, Schraut WH, Goyal A, Keljo DJ, Cross RK, Williams ED, Herfarth HH, Siegel CA, Oikonomou I, Brand MH, Hartman DJ, Tublin ME, Davis PL, Baidoo L, Szigethy E, Watson AR; IBD LIVE Physician Group. Collaborators (43) Barrie AM, Bensen SP, Bernasko N, Clarke K, Davison JM, Dhere T, Dragnev MC, Duerr RH, Dulai PS, Flasar MH, Gaslightwala I, Ghazi LJ, Grandinetti LM, Hashash JG, Heller MT, Holder-Murray J, Holubar SD, Isaacs K, Iskandar H, Klapproth JM, Koltun WA, Kuan SF, Levy L: The inflammatory bowel disease live interinstitutional and interdisciplinary videoconference education (IBD LIVE) series. Inflamm Bowel Dis : 2014.

Woolard Shani H, Razvi Mohammed A, Deng, Yi, Long Q, Tomolo A, Klapproth JMA: Consolidating Care for Crohn's Disease and Ulcerative Colitis Academy for Healthcare Improvement, Baltimore, MD : 2014.